Arrowhead Pharmaceuticals (0HI3)
LSE • 0HI3 • US04280A1007
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 26, 2026, ORTEX estimated 0.9% of free float sold short, 750.3 days to cover, cost to borrow 0.42%. Sign up for live short interest data.
Market Cap
6.92b USD | # 1144 in GB
Volume
1.14k shares | 130.72m USD
Shares Outstanding
141.25m
Free Float Shares
86.69% | 122.45m
